Tiger Brokers

HK StockDetailed Quotes
Provided by Tiger Fintech (Singapore) Pte. Ltd.

TRANSTHERA-B

53.150
-0.600-1.12%
Volume:265.58K
Turnover:13.68M
Market Cap:21.10B
PE:-67.77
High:54.050
Open:52.750
Low:48.660
Close:53.750
52wk High:58.050
52wk Low:20.200
Shares:396.90M
HK Float Shares:301.67M
Volume Ratio:1.46
T/O Rate:0.09%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.784
ROE:-41.98%
ROA:-24.05%
PB:36.86
PE(LYR):-67.77
PS:- -

Loading ...

OverviewCompanyNewsFilings

Company Profile

Company Name:
TRANSTHERA-B
Exchange:
SEHK
Establishment Date:
2014
Employees:
- -
Office Location:
Building 9, Accelerator Phase 2,3rd Floor,Biotech and Pharmaceutical Valley,Jiangbei New Area,Nanjing,Jiangsu Province,China
Website:
http://www.transtherabio.com
Zip Code:
210032
Phone:
86 25 5821 6200
Fax:
- -
Introduction:
TransThera Sciences (Nanjing) Inc is a China-based biopharmaceutical company principally focusing on discovering and developing innovative small molecule therapies for oncology, inflammatory and cardiometabolic diseases. The Company's core product Tinengotinib is a registrational clinical stage, internally discovered and developed, MTK inhibitor indicated for certain relapsed or refractory, drug-resistant solid tumors. The Company's oncology pipeline includes TT-00973 (against AXL), TT-01488 (For hematologic malignancies), TT-01688 (For inflammatory diseases.) and TT-00920 (For chronic heart failure). The products are capable of being efficacious in a broad range of cancer types (including prostate cancer, HCC, breast cancer, and BTC. It's also applied to cure hepatocellular carcinoma, breast cancer, biliary tract cancer and Pan-FGFR solid tumor.

Directors

Name
Position
WU Yong Qian
Chairman of the Board,Executive Director,Chairman of the Strategic and Development Committee,Member of the Nomination Committee
WU Di
Executive Director
XU Hai Yin
Independent Director,Member of the Strategic and Development Committee,Member of the Remuneration and Assessment Committee,Chairman of the Nomination Committee
ZHENG Zhe Lan
Independent Director,Chairman of the Remuneration and Assessment Committee,Member of the Nomination Committee,Audit Committee Member
LI Shu Pai
Independent Director,Audit Committee Chairman
GU Zhong Xin
Director,Member of the Strategic and Development Committee,Member of the Remuneration and Assessment Committee,Audit Committee Member
YI Hua
Director
ZHAO Wei Li
Supervisor,Employee Supervisor
MEI Jiang Hua
Supervisory
PANG Ya Jing
Supervisory

Shareholders

Name
Position
WU Yong Qian
CEO
WU Di
Vice General Manager,CFO
FENG Jie
Board Secretary,Corporate Secretary
Wong Tik
Corporate Secretary
FAN Jing
Other Senior Executives
CUI Song Xi
Other Senior Executives
PENG Peng
Other Senior Executives
SHENG Ze Juan
Other Senior Executives
SUN Cai Xia
Other Senior Executives